Inferior Vena Cava Filters - Testing and Labeling Requirements
This guidance addresses cardiovascular intravascular filters that are permanently implanted in the inferior vena cava to prevent thromboemboli from lower limbs reaching the heart and pulmonary circulation. It specifically covers filters with hooks/struts design converging at an apex, indicated for prevention of recurrent pulmonary embolism in specific clinical situations.
Recommended Actions
- Develop comprehensive pre-clinical testing plan addressing all performance aspects
- Conduct biocompatibility testing per ISO 10993-1
- Consider need for clinical investigation - discuss with FDA
- Prepare detailed test protocols with clear acceptance criteria
- Ensure statistical significance in test sample sizes
- Document all test results comprehensively
- Develop labeling with required indications, contraindications and MRI information
- Validate manufacturing processes
- Consider consulting FDA before initiating animal studies
- Prepare comprehensive risk analysis considering all potential complications
Key Considerations
Clinical testing
- Clinical investigations may be necessary for new or modified filter designs
- Study should demonstrate comparable complication rates to marketed filters
- Key complications to monitor:
- Insertion complications (sheath/introducer issues, deployment problems)
- Recurrent pulmonary embolism
- Filter migration (>5mm movement)
- Caval penetration
- Filter tilting and angulation
- Caval occlusion
- Filter embolization
- Death related to device
Non-clinical testing
- Simulated deployment testing
- Introducer/sheath suitability assessment
- Clot trapping ability evaluation
- Filter fracture resistance testing
- Caval perforation/migration testing
- Thrombogenicity assessment
Labelling
- Must include specific indications for use
- Must include contraindications (e.g., septic embolism)
- Must include MRI safety information (Safe, Compatible, or Non-Compatible)
Biocompatibility
- Testing according to ISO 10993-1 for permanent implant, blood-contacting devices
Safety
- Device fixation and endothelialization assessment
- Fatigue resistance evaluation
- Corrosion resistance testing
- Weld strength assessment
Other considerations
- MRI compatibility testing required
- Statistical analysis of all test results required
- Manufacturing process validation
Relevant Guidances
- Use of ISO 10993-1 for Biological Evaluation and Testing of Medical Devices
- Testing and Labeling of Medical Devices for Magnetic Resonance (MR) Environment Safety and Compatibility
- Recommended Format and Content for Non-Clinical Bench Performance Testing in Medical Device Premarket Submissions
Related references and norms
- ISO 10993-1: Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
Original guidance
- Inferior Vena Cava Filters - Testing and Labeling Requirements
- HTML
- Issue date: 1999-11-25
- Last changed date: 2020-03-18
- Status: FINAL
- Official FDA topics: Medical Devices, Cardiovascular, Premarket
- ReguVirta summary file ID: 0d2c50739f48e139eda3ad3ba930a118
This post is licensed under CC BY 4.0 by the author.